Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program
Diabetologie und Stoffwechsel · 01.04.2024 · 19 (S 01 S 01) · S75-S76
DOI: 10.1055/s-0044-1785385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologie und Stoffwechsel, erschienen am 01.04.2024. Verfasst von Philip Zeitler und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Does treatment with tirzepatide (TZP) improve glycemic control, body weight (BW) and cardiometabolic markers in participants with early-onset T2D?
Method
In this post-hoc analysis changes from baseline in mean HbA1c, BW, waist circumference (WC), and cardiometabolic markers including lipids, and blood pressure (BP) were compared in participants with early-onset (N=873, 20.5%) vs later-onset type 2 diabetes (T2D) (N=3394, 79.5%) at Week 40 (SURPASS-1, -2, -5) or Week 52 (SURPASS-3).
Results
No differential treatment effect was observed for participants with early- vs later-onset T2D. TZP treatment led to similar improvements in HbA1c and BW in both subgroups at Week 40/52 for all TZP doses. Furthermore, TZP (all doses) improved WC, lipids (triglycerides and HDL) and systolic BP similarly between the two groups.
Conclusion
TZP treatment led to similar improvements in HbA1c, BW and cardiometabolic markers (WC, lipids, systolic BP) in participants regardless of having early-onset or later-onset T2D. Publication History Article published online: 18 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Zeitler, P., Galindo, R. J., Davies, M. J., Bergman, B., Thieu, V. T., Nicolay, C., Allen, S., Lee, C. J., & Milek, K. (2024). Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program. Diabetologie und Stoffwechsel, 19(S 01 S 01), S75-S76. https://doi.org/10.1055/s-0044-1785385
Vancouver
Zeitler P, Galindo RJ, Davies MJ, Bergman B, Thieu VT, Nicolay C, et al. Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program. Diabetologie und Stoffwechsel. 2024;19(S 01 S 01):S75-S76. doi:10.1055/s-0044-1785385
BibTeX
@article{Zeitler2024,
author = {Zeitler, Philip and Galindo, Rodolfo J. and Davies, Melanie J. and Bergman, Brandon and Thieu, Vivian T. and Nicolay, Claudia and Allen, Sheryl and Lee, Clare J. and Milek, Karsten},
title = {Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program},
journal = {Diabetologie und Stoffwechsel},
year = {2024},
volume = {19},
number = {S 01 S 01},
pages = {S75--S76},
doi = {10.1055/s-0044-1785385}
}
EUVIMED